Non-invasive PET imaging using tracers that can accurately and repeatedly determine the level of PD-L1 or PD-1 expression in a cancer patient is a valuable tool that can certainly help to realize the full potential and predictive power of PD-L1 and PD-1 as prognostic biomarkers (33, 36, 229, 230). The gene discussed is CD274; the disease is cancer.